Sr. Medical Writer @ From August 2015 to Present (3 months) Associate Scientific Director @ title from 06/01/2015; previously Sr. Medical Writer Projects for biopharma/pharma clients, in numerous oncology and hematology indications: Content development for peer-to-peer medical professional education (e.g. physicians, MSLs, nurses/NPs,pharmacists) Business development focused research and analysis -comprehensive investigation of clinical and pre-clinical stage assets in the lung cancer space for a large pharmaceutical client. Project culminated with a series of internal and external meetings where actionable elements of our research were discussed in depth by a diverse group of stakeholders. Pharma/biopharma advisory boards in heme onc and solid tumor indications: content development, KOL engagement, and live coverage (including note taking, high-level and comprehensive strategic executive summaries) Content development for sales training Content development in rare and orphan diseases (heme) Close day-to-day interaction with clients From September 2014 to July 2015 (11 months) Greater Philadelphia AreaBusiness Development Consultant @ Evaluation (with the goal of in-license or acquisition) of early stage biotechnology assets from basic science, IP, & market perspectives. This work has directly resulted in the in-licensing (from a university source) of a pre-clinical infectious disease asset for murine model evaluation. Assessment of multiple clinical areas (including infectious disease,Type 2 Diabetes, obesity, ulcerative collitis, & Crohn's Disease) for the potential of developing novel microbiome-based therapeutics. This research has been integral in seeking out & obtaining long-term drug discovery research agreements with several large pharmaceutical companies (in metabolic disease & IBD). Development & maintenance of a large proprietary database cataloging bacteria (down to the sub-strain level when applicable) implicated in numerous disease states. This database includes a wealth of metadata about bacterial functional properties and clinical associations. From 2012 to 2014 (2 years) South San Francisco, CAStrategic Consultant/Medical Writer @ Worked with medical and marketing team pharma clients on strategic positioning (e.g. launch strategy and first-to-second generation therapeutic transition) Evaluated clinical therapeutic pipelines in numerous therapeutic areas (including oncology, neuroscience, metabolic disease, & infectious disease). Resultant deliverables have been used to aid both internal ETHOS business development decisions and pharma client pipeline-focus decisions Researched & created therapeutic area-specific decks for Medical Science Liaison (MSL) education Attended, & wrote analytical executive summaries for, pharma external advisory boards From 2011 to 2013 (2 years) Greater Philadelphia AreaLicensing Assistant @ Evaluated non-disclosed biotechnologies from UCSF research labs for commercial potential Wrote non-confidential disclosures & marketing emails for partnering outreach Initiated negotiations for out-licensing of university assets From 2010 to 2011 (1 year) San Francisco Bay Area

Doctor of Philosophy (PhD), Neuroscience @ University of Pennsylvania School of Medicine From 2003 to 2010 AB, Neuroscience/History @ Bowdoin CollegeInvestment Banking Institute From 2011 to 2011 Jonathan Raksin is skilled in: Biotech Asset Evaluation, Strategic Consulting, Medical Writing, Financial Modeling, Client Relations Skills, Programming, Matlab, Microsoft Office